Market Overview:
The global e-clinical trials market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for e-clinical trials solutions by pharmaceutical and biotechnology companies, hospitals, and medical laboratories. In addition, the growing adoption of cloud-based technologies is also contributing to the growth of this market. On the basis of type, the global e-clinical trials market is segmented into clinical data management system (CDMS) solutions, clinical trial management system (CTMS) solutions, electronic clinical outcomes assessment (eCOA) solutions, randomization and trial supply management (RTSM) solutions, and other types of e-clinical trials software. The CDMS solution segment is expected to account for the largest share of this market in 2018. This can be attributed to its ability to manage all aspects related to data collection and analysis during drug development process. On the basis of application, medical laboratories are expected account for majority share in 2018 followed by hospitals while pharmaceutical companies are projected as fastest growing application segment over forecast period owing rising number approvals for new drugs across globe .Regionally North America commanded largest revenue generating region due higher spending on healthcare sector with presence key players such as Oracle Corporation ,Pfizer Inc., Medidata Solutions among others followed by Europe .
Product Definition:
e-clinical Trials (ECT) are clinical trials that use information technology to support data collection, management, and analysis. ECT can improve the quality, efficiency and safety of clinical trials by facilitating collaboration among study team members, automating tasks such as patient randomization and reporting, and reducing the need for paper-based documentation.
Clinical Data Management System(CDMS) Solutions:
Clinical Data Management System (CDMS) Solutions are used for organizing, managing and analyzing clinical data. It is a software-based system that helps in reducing the time required to analyze clinical trial related information. The factors such as increasing R&D activities by pharmaceutical companies and growing demand for personalized medicine are expected to drive the market growth over the forecast period.
Clinical Trial Management System(CTMS) Solutions:
Clinical trial management systems solutions are used to plan, implement, and analyze clinical studies. CTMS helps in managing all the aspects of a clinical study from protocol design to post-marketing surveillance. It also helps in generating reports and extracts for regulatory submission & other research-related purposes.
Application Insights:
Medical laboratory was the largest application segment in the global e-clinical trials market, accounting for over 30.0% share of the total revenue in 2017. The growth can be attributed to increasing demand for advanced healthcare services coupled with an increase in R&D activities pertaining to bio-hazardous materials and diseases.
The hospital segment is expected to grow at a lucrative rate during the forecast period owing to growing investments by governments across various countries, including India and China, towards building world class hospitals that provide better care at lower costs. Furthermore, technological advancements such as implementation of electronic medical records (EMR) have improved efficiency and reduced paperwork significantly which has boosted market growth over recent years.
Pharmaceutical company is another key application segment slated to witness significant growth during the forecast period due to factors such as an increase in product launches coupled with stringent regulations relatedto clinical trials conducted by regulatory authorities aroundthe globe are driving this industry trend positively on a global scale.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of clinical trial participants and CROs that are actively involved in conducting e-clinical trials. The region is expected to maintain its dominance throughout the forecast period owing to continuous developments undertaken by various organizations, such as FDA, EMA, and ICH-GCP for maintaining high standards associated with clinical trials conducted within their regions.
The Asia Pacific region is anticipated to grow at a lucrative rate over the forecast period owing to increasing government initiatives pertaining towards adoption of advanced technologies across healthcare sectors in countries such as China & India. Furthermore, growing awareness about e-healthcare services among people will boost regional growth further during the estimated time frame. Moreover rising disposable income coupled with improving standard of living will also contribute towards this growth significantly (Kumar et al., 2016).
Growth Factors:
- Increasing demand for novel therapies and treatments: The increasing incidence of various diseases is driving the demand for novel therapies and treatments. This is resulting in the growth of the e-clinical trials market.
- Rising number of clinical trials: Clinical research organizations are increasingly adopting e-clinical trial solutions to manage their clinical studies more effectively and efficiently. This is contributing to the growth of the e-clinical trials market.
- Proliferation of digital technologies: The proliferation of digital technologies has led to a surge in adoption rates for e-clinical trial solutions among pharmaceutical and biotechnology companies, CROs, and healthcare providers worldwide. This is propelling the growth of the global e-clinical trials market .
Scope Of The Report
Report Attributes
Report Details
Report Title
e-clinical Trials Market Research Report
By Type
Clinical Data Management System(CDMS) Solutions, Clinical Trial Management System(CTMS) Solutions, Electronic Clinical Outcomes Assessment(eCOA) Solutions, Randomization and Trial Supply Management(RTSM) Solutions, Other
By Application
Medical Laboratory, Hospital, Pharmaceutical Company, Other
By Companies
Acceliant, ActiGraph, eClinicalWorks, IntrinsiQ Specialty Solutions, LMK Clinical Research Consulting, Lucidworks, Medrio, Parallel6, Symphony Clinical Research, Perceptive Informatics, EClinical Solutions, Ecrfplus, Clincase
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global e-clinical Trials Market Report Segments:
The global e-clinical Trials market is segmented on the basis of:
Types
Clinical Data Management System(CDMS) Solutions, Clinical Trial Management System(CTMS) Solutions, Electronic Clinical Outcomes Assessment(eCOA) Solutions, Randomization and Trial Supply Management(RTSM) Solutions, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Laboratory, Hospital, Pharmaceutical Company, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acceliant
- ActiGraph
- eClinicalWorks
- IntrinsiQ Specialty Solutions
- LMK Clinical Research Consulting
- Lucidworks
- Medrio
- Parallel6
- Symphony Clinical Research
- Perceptive Informatics
- EClinical Solutions
- Ecrfplus
- Clincase
Highlights of The e-clinical Trials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clinical Data Management System(CDMS) Solutions
- Clinical Trial Management System(CTMS) Solutions
- Electronic Clinical Outcomes Assessment(eCOA) Solutions
- Randomization and Trial Supply Management(RTSM) Solutions
- Other
- By Application:
- Medical Laboratory
- Hospital
- Pharmaceutical Company
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the e-clinical Trials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
E-clinical trials are clinical trials that use electronic health records (EHRs) to track patient data. This allows researchers to collect information about patients’ symptoms, treatments, and outcomes more accurately and efficiently than traditional clinical trial methods.
Some of the major players in the e-clinical trials market are Acceliant, ActiGraph, eClinicalWorks, IntrinsiQ Specialty Solutions, LMK Clinical Research Consulting, Lucidworks, Medrio, Parallel6, Symphony Clinical Research, Perceptive Informatics, EClinical Solutions, Ecrfplus, Clincase.
The e-clinical trials market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 e-clinical Trials Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 e-clinical Trials Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 e-clinical Trials Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the e-clinical Trials Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global e-clinical Trials Market Size & Forecast, 2020-2028
4.5.1 e-clinical Trials Market Size and Y-o-Y Growth
4.5.2 e-clinical Trials Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Clinical Data Management System(CDMS) Solutions
5.2.2 Clinical Trial Management System(CTMS) Solutions
5.2.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
5.2.4 Randomization and Trial Supply Management(RTSM) Solutions
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Medical Laboratory
6.2.2 Hospital
6.2.3 Pharmaceutical Company
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global e-clinical Trials Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 e-clinical Trials Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Clinical Data Management System(CDMS) Solutions
9.6.2 Clinical Trial Management System(CTMS) Solutions
9.6.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
9.6.4 Randomization and Trial Supply Management(RTSM) Solutions
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Medical Laboratory
9.10.2 Hospital
9.10.3 Pharmaceutical Company
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Clinical Data Management System(CDMS) Solutions
10.6.2 Clinical Trial Management System(CTMS) Solutions
10.6.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
10.6.4 Randomization and Trial Supply Management(RTSM) Solutions
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Medical Laboratory
10.10.2 Hospital
10.10.3 Pharmaceutical Company
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Clinical Data Management System(CDMS) Solutions
11.6.2 Clinical Trial Management System(CTMS) Solutions
11.6.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
11.6.4 Randomization and Trial Supply Management(RTSM) Solutions
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Medical Laboratory
11.10.2 Hospital
11.10.3 Pharmaceutical Company
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Clinical Data Management System(CDMS) Solutions
12.6.2 Clinical Trial Management System(CTMS) Solutions
12.6.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
12.6.4 Randomization and Trial Supply Management(RTSM) Solutions
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Medical Laboratory
12.10.2 Hospital
12.10.3 Pharmaceutical Company
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Clinical Data Management System(CDMS) Solutions
13.6.2 Clinical Trial Management System(CTMS) Solutions
13.6.3 Electronic Clinical Outcomes Assessment(eCOA) Solutions
13.6.4 Randomization and Trial Supply Management(RTSM) Solutions
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Medical Laboratory
13.10.2 Hospital
13.10.3 Pharmaceutical Company
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 e-clinical Trials Market: Competitive Dashboard
14.2 Global e-clinical Trials Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Acceliant
14.3.2 ActiGraph
14.3.3 eClinicalWorks
14.3.4 IntrinsiQ Specialty Solutions
14.3.5 LMK Clinical Research Consulting
14.3.6 Lucidworks
14.3.7 Medrio
14.3.8 Parallel6
14.3.9 Symphony Clinical Research
14.3.10 Perceptive Informatics
14.3.11 EClinical Solutions
14.3.12 Ecrfplus
14.3.13 Clincase
